AGIOS PHARMACEUTICALS, INC. Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for June 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Buy | J | 0.00 | 1,861 | 0 | 1,861 | 0 to 1.9 K |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | Flagship Ventures Fund 2007, L ... | 10% Owner | Sell | J | 0.00 | 1,930,369 | 0 | 1,930,369 | 3.9 M to 1.9 M (-50.00 %) |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 122,554 | 0 | 0 | 122.6 K to 0 (-100.00 %) |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Buy | J | 0.00 | 122,554 | 0 | 122,554 | 0 to 122.6 K |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 1,669,324 | 0 | 3,895,090 | 5.6 M to 3.9 M (-30.00 %) |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Buy | J | 0.00 | 17,747 | 0 | 17,747 | 0 to 17.7 K |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Sell | J | 0.00 | 122,554 | 0 | 0 | 122.6 K to 0 (-100.00 %) |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Buy | J | 0.00 | 122,554 | 0 | 122,554 | 0 to 122.6 K |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,669,324 | 0 | 3,895,090 | 5.6 M to 3.9 M (-30.00 %) |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 386,074 | 0 | 3,474,664 | 3.9 M to 3.5 M (-10.00 %) |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 2,230 | 0 | 2,230 | 0 to 2.2 K |
| Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 386,074 | 0 | 3,474,664 | 3.9 M to 3.5 M (-10.00 %) |
| Jun 24 2014 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | P | 43.98 | 2,300 | 101,154 | 48,883 | 46.6 K to 48.9 K (+4.94 %) |
| Jun 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 2,004 | 937 | 322,313 | |
| Jun 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 50.05 | 2,004 | 100,300 | 30,000 | 32 K to 30 K (-6.26 %) |
| Jun 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 2,004 | 937 | 32,004 | 30 K to 32 K (+6.68 %) |
| Jun 16 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 45.27 | 5,000 | 226,350 | 188,090 | 193.1 K to 188.1 K (-2.59 %) |
| Jun 09 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Option Exercise | A | 35.16 | 13,250 | 465,870 | 13,250 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Option Exercise | A | 35.16 | 12,500 | 439,500 | 12,500 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Option Exercise | A | 35.16 | 12,500 | 439,500 | 12,500 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Option Exercise | A | 35.16 | 12,500 | 439,500 | 157,954 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 35.16 | 14,000 | 492,240 | 29,113 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 35.16 | 14,000 | 492,240 | 37,500 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 35.16 | 12,500 | 439,500 | 22,500 | |
| Jun 05 2014 | AGIO | AGIOS PHARMACEUTIC ... | KARSEN PERRY A | Director | Option Exercise | A | 35.16 | 12,500 | 439,500 | 12,500 | |
| Jun 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 35.01 | 3,700 | 129,537 | 193,090 | 196.8 K to 193.1 K (-1.88 %) |
| Jun 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 33.87 | 3,300 | 111,771 | 196,790 | 200.1 K to 196.8 K (-1.65 %) |
| Jun 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 4,500 | 2,104 | 324,317 | |
| Jun 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 33.76 | 4,500 | 151,920 | 30,000 | 34.5 K to 30 K (-13.04 %) |
| Jun 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 4,500 | 2,104 | 34,500 | 30 K to 34.5 K (+15.00 %) |
| Jun 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 35.16 | 120,000 | 4,219,200 | 120,000 |